Comparision of topical kojic acid and topical tranexamic acid in patients of post inflammatory hyperpigmentatio
Phase 3
- Conditions
- Health Condition 1: L810- Postinflammatory hyperpigmentation
- Registration Number
- CTRI/2023/10/059029
- Lead Sponsor
- Mahatma Gandhi Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with post inflammatory hyperpigmentation, presenting to dermatology outpatient department.
2.Patients of both genders and age group 18-50 years old.
3.Patients willing with informed consent to participate in the study.
4.Patients with normal coagulation profile (bleeding time and clotting time).
Exclusion Criteria
1.Patients having uncontrolled medical or surgical illness and other major systemic diseases.
2.Patients who are not willing for the study or follow-up.
3.Patients who had preexisting bleeding, coagulation, thromboembolic, or psychological disorders.
4.Patients not willing for the study or for follow-up.
5.Patients with pregnancy or on lactation or oral contraceptives
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method decrease in pigmentationTimepoint: zero, four, eight and twelve weeks
- Secondary Outcome Measures
Name Time Method any irritation with the productsTimepoint: zero, four, eight and twelve weeks